Multiple antibody detection in ‘seronegative’ myasthenia gravis patients
- 4 May 2017
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 24 (6) , 844-850
Abstract
Background and purpose: Myasthenia gravis (MG) is an autoimmune disease caused by antibody mediated impairment in the neuromuscular junction. Seronegative MG (SNMG) without antibodies against acetylcholine receptor (AChR) and muscle‐specific kinase (MuSK) by routine assays accounts for about 20% of all MG patients.Methods: Plasma from 81 Chinese MG patients previously found to be seronegative was tested by routine assays for AChR and MuSK antibodies. These samples were screened by (i) a novel, highly sensitive radioimmunoassay for AChR antibodies; (ii) cell‐based assays for clustered AChR, MuSK and lipoprotein receptor‐related protein 4 (LRP4) antibodies; (iii) a radioimmunoassay for titin antibodies.Results: Antibodies to AChR, MuSK, LRP4 and titin were found in 25% (20/81), 4% (3/81), 7% (6/81) and 6% (5/78) of SNMG patients, respectively. In total, 37% of SNMG patients were found to be positive for at least one of the tested antibodies. AChR antibody positive patients had more severe disease (P = 0.008) and a trend towards fewer remissions/minimal manifestations than AChR antibody negative patients. The four patients with coexistence of antibodies had more severe disease, whilst the seronegative patients had milder MG (P = 0.015).Conclusions: Detection of multiple muscle antibodies by more sensitive assays provides additional information in diagnosing and subgrouping of MG and may guide MG treatment.Keywords
Funding Information
- European Commission (645648)
- Association Française contre les Myopathies (18491)
- Minnesota Department of Agriculture (255236)
- National Natural Science Foundation of China (81070963)
- Natural Science Foundation of Shandong Province (ZR2010HM019)
This publication has 20 references indexed in Scilit:
- Seronegative Myasthenia Gravis—A Vanishing Disorder?JAMA Neurology, 2016
- Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patientsJournal of Neuroimmunology, 2016
- Myasthenia gravis — autoantibody characteristics and their implications for therapyNature Reviews Neurology, 2016
- Titin antibodies in “seronegative” myasthenia gravis — A new role for an old antigenJournal of Neuroimmunology, 2016
- Myasthenia gravis: subgroup classification and therapeutic strategiesThe Lancet Neurology, 2015
- Use of cell-based assays in myasthenia gravis and other antibody-mediated diseasesExperimental Neurology, 2015
- MuSK autoantibodies in myasthenia gravis detected by cell based assay — A multinational studyJournal of Neuroimmunology, 2015
- A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravisJournal of Autoimmunity, 2014
- Antititin antibody in early- and late-onset myasthenia gravisActa Neurologica Scandinavica, 2014
- IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†Brain, 2008